Literature DB >> 1701417

Identification of seven surface-exposed Brucella outer membrane proteins by use of monoclonal antibodies: immunogold labeling for electron microscopy and enzyme-linked immunosorbent assay.

A Cloeckaert1, P de Wergifosse, G Dubray, J N Limet.   

Abstract

A panel of monoclonal antibodies (MAbs) to seven Brucella outer membrane proteins were characterized. These antibodies were obtained by immunizing mice with sodium dodecyl sulfate-insoluble (SDS-I) fractions, cell walls, or whole bacterial cells of Brucella abortus or B. melitensis. Enzyme-linked immunosorbent assays were used to screen the hybridoma supernatants and to determine their binding at the surface of rough and smooth B. abortus and B. melitensis cells. The outer membrane proteins (OMPs) recognized by these antibodies were the proteins with molecular masses of 25 to 27 kDa and 36 to 38 kDa (porin) (major proteins) and the proteins with molecular masses of 10, 16.5, 19, 31 to 34, and 89 kDa (minor proteins). Surface exposure of these OMPs was visualized by electron microscopy by using the MAbs and immunogold labeling. Binding of the MAbs on whole rough bacterial cells indicates that the 10-, 16.5-, 19-, 25- to 27-, 31- to 34-, 36- to 38-, and 89-kDa OMPs are exposed at the cell surface. However, enzyme-linked immunosorbent assay results indicate a much better binding of the anti-OMP MAbs on rough strains than on the corresponding smooth strains except for the anti-19-kDa MAb. Immunoelectron microscopy showed that on smooth B. abortus cells only the 89- and 31- to 34-kDa OMPs were not accessible to the MAbs tested. Binding of the anti-31- to 34-kDa MAb at the cell surface was observed for the rough B. abortus cells and for the rough and smooth B. melitensis cells. These results indicate the importance of steric hindrance due to the presence of the long lipopolysaccharide O side chains in the accessibility of OMPs on smooth Brucella strains and should be considered when undertaking vaccine development.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1701417      PMCID: PMC313765          DOI: 10.1128/iai.58.12.3980-3987.1990

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  39 in total

1.  Protective action of monospecific anti-Brucella sera in mice.

Authors:  D SULITZEANU; L JONES; A W STABLEFORTH
Journal:  Nature       Date:  1955-06-11       Impact factor: 49.962

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 3.  Covalent lipoprotein from the outer membrane of Escherichia coli.

Authors:  V Braun
Journal:  Biochim Biophys Acta       Date:  1975-10-31

4.  Immunization against Brucella with killed vaccines. Immunizing activity in mice of Brucella cell walls and of fractions derived from them.

Authors:  G Rasooly; A L Olitzki; D Sulitzeanu
Journal:  Isr J Med Sci       Date:  1966 Sep-Oct

5.  Immunization by an insoluble fraction extracted from Brucella melitensis: immunological and chemical characterization of the active substances.

Authors:  A Lopez-Merino; J Asselineau; A Serre; J Roux; S Bascoul; C Lacave
Journal:  Infect Immun       Date:  1976-02       Impact factor: 3.441

6.  [Structure and constituents of Brucella. Characterization and biological properties of the fractions].

Authors:  G Dubray; M Plommet
Journal:  Dev Biol Stand       Date:  1976

7.  Effectiveness of natural and synthetic complexes of porin and O polysaccharide as vaccines against Brucella abortus in mice.

Authors:  A J Winter; G E Rowe; J R Duncan; M J Eis; J Widom; B Ganem; B Morein
Journal:  Infect Immun       Date:  1988-11       Impact factor: 3.441

8.  Evidence of heterogeneity of lipopolysaccharides among Brucella biovars in relation to A and M specificities.

Authors:  G Dubray; J Limet
Journal:  Ann Inst Pasteur Microbiol       Date:  1987 Jan-Feb

9.  Some structural and biological properties of Brucella endotoxin.

Authors:  D Leong; R Diaz; K Milner; J Rudbach; J B Wilson
Journal:  Infect Immun       Date:  1970-02       Impact factor: 3.441

10.  Effect of lipopolysaccharide structure on reactivity of antiporin monoclonal antibodies with the bacterial cell surface.

Authors:  A T Bentley; P E Klebba
Journal:  J Bacteriol       Date:  1988-03       Impact factor: 3.490

View more
  68 in total

1.  Characterization of new members of the group 3 outer membrane protein family of Brucella spp.

Authors:  Imed Salhi; Rose-Anne Boigegrain; Jan Machold; Christoph Weise; Axel Cloeckaert; Bruno Rouot
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

2.  Cloning of a Brucella melitensis group 3 antigen gene encoding Omp28, a protein recognized by the humoral immune response during human brucellosis.

Authors:  L E Lindler; T L Hadfield; B D Tall; N J Snellings; F A Rubin; L L Van De Verg; D Hoover; R L Warren
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

3.  Systematic targeted mutagenesis of Brucella melitensis 16M reveals a major role for GntR regulators in the control of virulence.

Authors:  Valérie Haine; Audrey Sinon; Frédéric Van Steen; Stéphanie Rousseau; Marie Dozot; Pascal Lestrate; Christophe Lambert; Jean-Jacques Letesson; Xavier De Bolle
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

4.  Comparative diagnostic evaluation of OMP31 gene based TaqMan® real-time PCR assay with visual LAMP assay and indirect ELISA for caprine brucellosis.

Authors:  Suman Saini; V K Gupta; K Gururaj; D D Singh; R V S Pawaiya; N K Gangwar; A K Mishra; Deepak Dwivedi; Dimple Andani; Ashok Kumar; T K Goswami
Journal:  Trop Anim Health Prod       Date:  2017-06-21       Impact factor: 1.559

5.  Regulation of the mitogen-activated protein kinases by Brucella spp. expressing a smooth and rough phenotype: relationship to pathogen invasiveness.

Authors:  María P Jiménez de Bagüés; Antoine Gross; Annie Terraza; Jacques Dornand
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

6.  FtcR is a new master regulator of the flagellar system of Brucella melitensis 16M with homologs in Rhizobiaceae.

Authors:  S Léonard; J Ferooz; V Haine; I Danese; D Fretin; A Tibor; S de Walque; X De Bolle; J-J Letesson
Journal:  J Bacteriol       Date:  2006-10-20       Impact factor: 3.490

7.  Cloning and expression of portions of the 34-kilodalton-protein gene of Mycobacterium paratuberculosis: its application to serological analysis of Johne's disease.

Authors:  M De Kesel; P Gilot; M C Misonne; M Coene; C Cocito
Journal:  J Clin Microbiol       Date:  1993-04       Impact factor: 5.948

8.  Brucella abortus inhibits major histocompatibility complex class II expression and antigen processing through interleukin-6 secretion via Toll-like receptor 2.

Authors:  Paula Barrionuevo; Juliana Cassataro; M Victoria Delpino; Astrid Zwerdling; Karina A Pasquevich; Clara García Samartino; Jorge C Wallach; Carlos A Fossati; Guillermo H Giambartolomei
Journal:  Infect Immun       Date:  2007-11-05       Impact factor: 3.441

9.  The lipopolysaccharide of Brucella abortus BvrS/BvrR mutants contains lipid A modifications and has higher affinity for bactericidal cationic peptides.

Authors:  Lorea Manterola; Ignacio Moriyón; Edgardo Moreno; Alberto Sola-Landa; David S Weiss; Michel H J Koch; Jörg Howe; Klaus Brandenburg; Ignacio López-Goñi
Journal:  J Bacteriol       Date:  2005-08       Impact factor: 3.490

10.  Protection of mice against Brucella abortus 544 challenge by vaccination with recombinant OMP28 adjuvanted with CpG oligonucleotides.

Authors:  Purushottam Kaushik; Dhirendra K Singh; S Vinoth Kumar; Ashok K Tiwari; Gunjan Shukla; Shanker Dayal; Pallav Chaudhuri
Journal:  Vet Res Commun       Date:  2009-12-16       Impact factor: 2.459

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.